OncoLink en espanõl
Share
Types of Cancer > Lymphomas > Non-Hodgkin's Disease > News
April 2009
Lower survival with primary breast non-Hodgkin's lymphoma
February 2009
Lymphocyte count predicts survival after relapse of diffuse large B-cell lymphoma
B-cell clones seen years before leukemia diagnosis
January 2009
Gene mutations predict poor outcome of B-cell progenitor-ALL
December 2008
Diabetes linked to moderately increased risk of non-Hodgkin's lymphoma
October 2008
C. psittaci linked to ocular adnexal MALT lymphoma
September 2008
Trifunctional bispecific antibody kills B-cell lymphoma cells
August 2008
B-cell lymphocytosis linked to chronic lymphocytic leukemia
July 2008
Pegylated liposomal doxorubicin effective in hard-to-treat cutaneous T-cell lymphoma
February 2008
Hepatitis C confirmed as a risk factor for non-Hodgkin's lymphoma
January 2008
Radiotherapy suitable for most primary cutaneous B-cell lymphomas
Watch-and-wait strategy appropriate in many with residual MALT lymphoma
December 2007
Investigational drug Treanda effective in non-Hodgkin's lymphoma
IL-2 immunotoxin boosts vaccine-mediated T-cell immunity
November 2007
Most cases of T-cell precursor ALL appear to develop after birth
September 2007
Allogeneic T-cell therapy effective against post-transplant EBV-related tumors
T-cell coregulatory B7-H3 ligand is a marker of aggressive prostate cancer
July 2007
Incidence of cutaneous T-cell lymphoma has increased
May 2007
Enzastaurin delays progression in diffuse large B-cell lymphoma
Lung involvement in cutaneous T-cell lymphoma a poor sign
December 2006
Pair of microRNA molecules controls major oncogene in B-cell leukemia
September 2006
NSAID use is not linked to non-Hodgkin's lymphoma
July 2006
EU approves MabThera for rheumatoid arthritis and non-Hodgkin's lymphoma
June 2006
FDA grants Merck & Co a priority review for Zolinza in T-cell lymphoma
May 2006
Leukemia, lung cancer risk higher in non-Hodgkin's lymphoma survivors
Fludarabine effective in non-Hodgkin's lymphoma
Polio vaccine not tied to non-Hodgkin's lymphoma
March 2006
Genentech and Biogen file Rituxan with FDA for non-Hodgkin's lymphoma
December 2005
Gemcitabine effective first-line treatment for cutaneous T-cell lymphoma
Overeating and underactivity increase non-Hodgkin's lymphoma risk
Immune-related disorders tied to non-Hodgkin's lymphoma
Positive results seen with non-Hodgkin's lymphoma vaccine
PCB, furan exposure increases risk of non-Hodgkin's lymphoma
November 2005
Combination helpful in refractory non-Hodgkin's lymphoma
Heavy antibiotic use tied to increased non-Hodgkin's lymphoma risk
October 2005
Autoimmune disease tied to non-Hodgkin's lymphoma
Primed T-cell transfer after stem cell transplant boosts immunity
August 2005
Antigen-based lymphoma vaccine effective after B-cell depletion
June 2005
PCB exposure may increase non-Hodgkin's lymphoma risk
SLE linked to increased cancer risk, notably non-Hodgkin's lymphoma
Alcohol use linked to decreased risk of non-Hodgkin's lymphoma
Intensive therapy no better than CHOP for T-cell non-Hodgkin lymphoma
New regimen effective for refractory non-Hodgkin's lymphoma
March 2005
PUVA induces long-term remissions with cutaneous T-cell lymphoma
February 2005
B-cell lymphoma course tied to chromosomal aberrations
December 2004
Sunshine may reduce non-Hodgkin's lymphoma risk
August 2004
Etanercept shows promise in early cutaneous T-cell lymphoma
July 2004
HCV infection tied to non-Hodgkin's lymphoma
Endothelial cells in B-cell lymphomas tumor-related
June 2004
Non-myeloablative cell transplant effectivel in recurrent non-Hodgkin's lymphoma
April 2004
Six-gene profile predicts overall survival in diffuse large-B-cell lymphoma
Stem cell transplantation restores T-cell immunity in JAK3 deficiency
March 2004
Diet influences the risk of non-Hodgkin's lymphoma
Ganciclovir may aid chemotherapy in EBV-driven B-cell lymphoma
November 2003
Rituxan meets goal in non-Hodgkin's lymphoma trial
June 2003
Lentiviral vaccine injection transduces DCs, elicits T-cell response in mice
April 2003
HCV infection linked to non-Hodgkin's lymphoma risk in U.S.
September 2002
Melanoma patients respond to T-cell transplant after lymphodepletion
Wine consumption associated with lower risk of non-Hodgkin's lymphoma in men
June 2002
Cancer vaccines generate persistent T-cell response to HER-2/neu protein
May 2002
Immunotherapy shows promise for non-Hodgkin's lymphoma
March 2002
Idiotype-pulsed dendritic cell vaccination can induce regression of B-cell NHL
Simian virus 40 linked to non-Hodgkin's lymphoma
December 2001
Epratuzumab may enhance rituximab therapy for non-Hodgkin's lymphoma
Cancer vaccine elicits response in non-Hodgkin's lymphoma
November 2001
T-cell lymphoma transmitted by allogeneic bone marrow transplantation
July 2001
Purified T-cell transplant treats leukemia, prevents toxicity in mice
May 2001
Risk of T-cell lymphomas increased in people with AIDS
Chemotherapy effective for HIV-associated non-Hodgkin's lymphoma
March 2001
Reciprocal risk increase seen between melanoma and non-Hodgkin's lymphoma
October 2000
Telomerase reverse transcriptase immortalizes tumor-specific CD8+ T-cell clones
September 2000
Superantigen T-cell response enhances antitumor activity
Fused ovarian cancer and dendritic cells stimulate T-cell response against tumor
August 2000
a potential treatment for B-cell malignancies
Inex's non-Hodgkins lymphoma drug gets FDA fast track status
Engineered dendritic cells enhance T-cell responses
July 2000
Bexxar enters phase II trial for intermediate-stage non-Hodgkin's lymphoma
Endostatin plus chemotherapy treats non-Hodgkin's lymphoma in mice
Brca1 required for T-cell development
June 2000
X-linked gene may be involved in development of non-Hodgkin's lymphoma
FDA approves Ligand's cutaneous T-cell lymphoma treatment Targretin gel
May 2000
Rituximab may be suitable as initial systemic therapy for non-Hodgkin's lymphoma
April 2000
HAART increases survival rate of HIV-infected patients with non-Hodgkin's lymphoma
March 2000
DNA repair gene maintains genomic stability, suppresses B-cell tumors in mice
December 1999
Gemcitabine useful as monotherapy for aggressive non-Hodgkin's lymphomas
Ifosfamide/carboplatin/etoposide superior to other regimens for non-Hodgkin's lymphoma
April 1999
Common precursors identified in patients with both Hodgkin's disease, non-Hodgkin's lymphoma
March 1999
Pesticides may increase risk of non-Hodgkin's lymphoma in men
Latitude, but not occupation, links sunlight exposure to non-Hodgkin's lymphoma
February 1999